Skip to content

Dr. Joke De Buck

Active Private limited companyfounded 2018active for 8 yearsProfessor Piccardlaan 30, 2610 AntwerpKBO/BCE: BE 0713.517.251

Lifetime

7 annual accounts with figures on one time axis
peak of €236,353 in 2023
€150,398▼ 14.1%
peak of €174,691 in 2023
€97,551▼ 18.1%
peak of €412,142 in 2021
€18,651▲ 0.3%
€124,618▼ 25.3%
Board1 name since 2018
1 director
Documentsfilings and deeds
17-02-2026164 days before the deadline
2025micro format
Gross margin from €175,151 to €150,398Dividend €97,500Debts from €166,784 to €124,618Cash from €81,969 to €53,602

Key points

from the 2025 annual accounts

Equity

€18,651 from €412,142 in 2021

Equity fell by 95% in 4 years.

Turnover

≈ €280,000 estimated

The micro format states no turnover.

Debts

€124,618 87% of the balance sheet
Suppliers 6%Taxes and wages 12%Other 83%

Filings

7 annual accounts since 2019
AprilJune31 JulyOctober202020222024

The last five annual accounts were filed 14 to 164 days before the end of the period.

Position in the sector

13.0%

Lower solvency than 84% of companies in human health. The sector median is 63.0%, over 21,385 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 6,713 companies had the same profile as Dr. Joke De Buck has now. Each dot stands for 17 companies, two years later.

95.8%
were still trading
2.2%
stopped another way
1.9%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 6,713 companies, not a prediction for Dr. Joke De Buck. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 13-11-2018
  • 100 sharesdeed of 16-11-2018
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0713517251
changes role from manager to director Legal-form conversion: from private limited company (pre-2019) to private limited company · General meeting of 03-12-2019 · Gazette deed
Incorporation Founding capital of €18,600, 100 shares · Founded by (comparante) · appointed as manager · published on 16-11-2018 · Gazette deed
First establishment Professor Piccardlaan 30, Antwerp
All 14 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Joke De Buck Antwerp €143,268 €150,398 13.0% -
DRSD Edegem €160,618 €160,943 11.6% -
Dr. Heymeriks Cardioloog Ostend €152,486 €143,376 28.5% -
Dr. C. HUBERT Urologie Liège €130,400 €142,968 15.6% -
Docteur Laure Ysebrant de Lendonck Uccle €146,765 €167,023 8.6% -
DOKTER TINE CORNELIS Oud-Heverlee €150,897 €169,502 97.1% 0
SLvE Anesthésie Liège €145,408 €136,827 34.3% -

These companies have the same main activity as Dr. Joke De Buck: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €130,000 and €161,000, founded between 2017 and 2019.

Official details

Source: KBO
Status
Active since 13-11-2018Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.281.784.7452610 Antwerp, since 13-11-2018
Financial year end
31 December
Peppol
Reachable since 27-01-2026
Company details

Annual accounts 2025

€143,268▼ 22.7%
Filing
Filed on 17-02-2026, 164 days before the end of the filing period
Financials

Insights on Dr. Joke De Buck

Dr. Joke De Buck files the micro format. That format states no turnover. The gross margin fell from €206,218 in 2019 to €150,398 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Joke De Buck

What is the company number of Dr. Joke De Buck?
The company number of Dr. Joke De Buck is 0713.517.251. The VAT number is the same number with BE in front: BE 0713.517.251.
Where is Dr. Joke De Buck based?
The registered office is at Professor Piccardlaan 30, 2610 Antwerp.Company details
What does Dr. Joke De Buck do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Joke De Buck?
Dr. Joke De Buck is a private limited company (BV).
When was Dr. Joke De Buck founded?
Dr. Joke De Buck was founded on 13-11-2018.
Is Dr. Joke De Buck still active?
Yes, Dr. Joke De Buck is an active enterprise in the KBO register.
What is the turnover of Dr. Joke De Buck?
The turnover in financial year 2025 is about €280,000. This figure is estimated from the gross margin of €150,398 and 40 comparable companies (NACE 86220). It probably lies between €240,000 and €370,000.Financials
Is Dr. Joke De Buck profitable?
In financial year 2025, Dr. Joke De Buck made a profit of €97,551.
Where can I find the annual accounts of Dr. Joke De Buck?
Dr. Joke De Buck filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Joke De Buck due?
Dr. Joke De Buck must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.